Pre-made Glenzocimab benchmark antibody ( Fab, anti-GP6 therapeutic antibody, Anti-BDPLT11/GPIV/GPVI Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-247

Pre-Made Glenzocimab biosimilar, Fab, Anti-GP6 Antibody: Anti-BDPLT11/GPIV/GPVI therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-247-1mg 1mg 3090
GMP-Bios-ab-247-10mg 10mg Inquiry
GMP-Bios-ab-247-100mg 100mg Inquiry
GMP-Bios-ab-247-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Glenzocimab biosimilar, Fab, Anti-GP6 Antibody: Anti-BDPLT11/GPIV/GPVI therapeutic antibody
INN Name Glenzocimab
TargetGP6
FormatFab
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2018
Year Recommended2019
CompaniesActicor Biotech
Conditions Approvedna
Conditions ActiveStroke;COVID-19
Conditions Discontinuedna
Development Techna